IP Library Granted Patent US 8,722,656
Granted Patent B2
US 8,722,656 · App. 13/459,851 · Granted May 13, 2014

Cephalosporins useful as antibacterial agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,722,656
App. No.
13/459,851
Granted
May 13, 2014
Kind
B2
Abstract

The present invention provides novel cephalosporin derivatives of formula I, their analogues, their use for the treatment of infections in mammals, pharmaceutical composition containing these novel compounds, and methods for the preparation of these compounds.

Claims (54)

1. A compound of formula I

or a pharmaceutically acceptable salt thereof wherein:

R 1 is —NR 4 R 5 , —SO 2 R 6 , —C(═O)NR 4 R 4 , —SR 4 , —S(C═O)R 4 , —C 1-4 alkyl substituted with —SR 4 , —S(C═O)R 4 , —(═O)NR 4 R 5 , or —SO 2 R 6 ; or R 1 is —OC 1-8 alkyl substituted with —SR 4 , —S(C═OR 4 , —C(═O)NR 4 R 5 , or —SO 2 R 6 ;

R 2 and R 3 are independently —H, —OH, —CN, halo, —NO 2 , —C 1-10 alkyl, —OC 1-10 alkyl, —N(R 4 ) 2 ;

R 4 is —H or —C 1-10 alkyl;

R 5 is —SO 2 R 4 ′, —C(═)C 1-10 alkyl;

R 6 is H, C 1-6 alkyl, or NR 4 R 4 ;

at each occurrence, C 1-10 alkyl is optionally substituted with —OH, —CN, halo, —NO 2 , —OC 1-6 alkyl, —SH, —SC 1-4 alkyl, —S(C═O)C 1-4 alkyl, or —O(C═O)C 1-4 alkyl; and

n is 1, 2, or 3.

2. A compound of claim 1 wherein R 1 is —NR 4 R 5 , —SO 2 R 6 , or —C 1-4 alkyl substituted with —SR 4 , —S(C═O)R 4 , —C(═O)NR 4 R 5 , or —SO 2 R 6 .

3. A compound of claim 1 wherein R 1 is —C 1-4 alkyl substituted with —SR 4 , —S(C═O)R 4 , or —SO 2 R 6 .

4. A compound of claim 1 wherein R 1 is a methyl substituted with —SR 4 , —S(C═O)R 4 , or

—SO 2 R 6 .

5. A compound of claim 1 wherein R 1 is a methyl substituted with —SH, or —S(C═O)CH 3 .

6. A compound of claim 2 wherein R 1 is —NHC 1-6 alkyl substituted with —SH, —SC 1-4 alkyl, or —S(C═O)C 1-4 alkyl.

7. A compound of claim 1 wherein R 2 is H or C 1-4 alkyl.

8. A compound of claim 1 wherein R 2 is C 1-4 alkyl.

9. A compound of claim 1 wherein R 3 is H, OH, or C 1-6 alkyl optionally substituted with OH, CN, halo, NO 2 , OC 1-6 alkyl, SH, SC 1-4 alkyl, S(C═O)C 1-4 alkyl, or —O(C═O)C 1-4 alkyl.

10. A compound of claim 1 wherein R 3 is H or C 1-4 alkyl optionally substituted with OH, OC 1-4 alkyl, SH, or SC 1-4 alkyl.

11. A compound of claim 1 wherein R 1 is —NR 4 R 5 , —SO 2 R 6 , —C(═O)NR 4 R 4 , —SR 4 , —S(C═O)R 4 , —C 1-4 alkyl substituted with —SR 4 , —S(C═O)R 4 , —C(═O)NR 4 R 5 , or —SO 2 R 6 ; or R 1 is —OC 1-8 alkyl substituted with —SR 4 , —S(C═O)R 4 , —C(═O)NR 4 R 5 , or —SO 2 R 6 ; R 2 is H or C 1-4 alkyl; and R 3 is H or C 1-4 alkyl optionally substituted with OH, OC 1-4 alkyl, SH, or SC 1-4 alkyl.

12. A compound of claim 1 wherein R 1 is —NR 4 R 5 , —SO 2 R 6 , or —C 1-4 alkyl substituted with —SR 4 , —S(C═O)R 4 , —C(═O)NR 4 R 5 , or —SO 2 R 6 ; R 2 is H or C 1-4 alkyl; and R 3 is H or C 1-4 alkyl optionally substituted with OH, OC 1-4 alkyl, SH, or SC 1-4 alkyl.

13. A compound of claim 1 wherein R 1 is —C 1-4 alkyl substituted with —SR 4 , —S(C═O)R 4 , or —SO 2 R 6 ; R 2 is H or C 1-4 alkyl; and R 3 is H or C 1-4 alkyl.

14. A compound of claim 1 wherein R 1 is a methyl substituted with —SH, or —S(C═O)CH 3 ; R 2 is H or C 1-4 alkyl; and R 3 is H or C 1-4 alkyl.

15. A compound of claim 1 wherein R 1 is a methyl substituted with —SH, or —S(C═O)CH 3 ; R 2 is H or methyl; and R 3 is H or methyl.

16. A compound of claim 1 which is

1) (6R,7R)-3-{3-[(acetylsulfanyl)methyl]-2-methylbenzyl}-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

2) (6R,7R)-3-{4-[(acetylsulfanyl)methyl]-2-methylbenzyl}-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

3) (6R,7R)-3-{5-[(acetylsulfanyl)methyl]-2-methylbenzyl}-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

4) (6R,7R)-3-{3-[(acetylsulfanyl)methyl]-2,6-dimethylbenzyl}-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

5) (6R,7R)-3-{3-[(acetylsulfanyl)methyl]-5-(hydroxymethyl)-2,6-dimethylbenzyl}-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

6) (6R,7R)-3-{4-[(acetylsulfanyl)methyl]-2,6-dimethylbenzyl}-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

7) (6R,7R)-3-(3-{[(acetylsulfanyl)acetyl]amino}-2-methylbenzyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

8) (6R,7R)-3-(5-{[(acetylsulfanyl)acetyl]amino}-2-methylbenzyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

9) (6R,7R)-3-(4-{[(acetylsulfanyl)acetyl](propyl)amino}benzyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

10) (6R,7R)-3-(3-{[(acetylsulfanyl)acetyl](methyl)amino}benzyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

11) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(3-{[(methylsulfanyl)acetyl]amino}benzyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

12) (6R,7R)-3-(3-{[(acetylsulfanyl)acetyl]amino}benzyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

13) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-3-{3-[propan-2-yl(sulfanylacetyl)amino]benzyl}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

14) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{2,3-dimethyl-5-[(methylsulfonyl)amino]benzyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

15) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{2,4-dimethyl-5-[(methylsulfonyl)amino]benzyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

16) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{3-[methyl(methylsulfonyl)amino]benzyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

17) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{3-[(methylsulfonyl)amino]benzyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

18) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{3-methoxy-5-[(methylsulfonyl)amino]benzyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

19) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{3-methyl-5-[(methylsulfonyl)amino]benzyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

20) (6R,7R)-3-(5-{[2-(acetylsulfanyl)ethyl]sulfamoyl}-2-methylbenzyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

21) (6R,7R)-3-(3-{[2-(acetylsulfanyl)ethyl](ethyl)sulfamoyl}benzyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

22) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[2-methoxy-5-(methylsulfamoyl)benzyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

23) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[3-(methylsulfamoyl)benzyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

24) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[2-methyl-5-(methylsulfamoyl)benzyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

25) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[3-(dimethylsulfamoyl)benzyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

26) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[3-methoxy-5-(methylsulfamoyl)benzyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;

27) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[3-methyl-5-(methylsulfamoyl)benzyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; or

28) (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[2-methyl-4-(methylsulfonyl)benzyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid.

17. A pharmaceutical composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2015
From: ZOETIS LLC
To: ZOETIS SERVICES LLC
Reel/Frame 035651/0817 →
CHANGE OF NAME Recorded Mar 28, 2013
From: AH USA 42 LLC
To: ZOETIS LLC
Reel/Frame 030119/0866 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2012
From: PFIZER INC.
To: AH USA 42 LLC
Reel/Frame 029087/0093 →